D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 54 Citations 11,019 197 World Ranking 7898 National Ranking 549

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Gene

His main research concerns Cell biology, Biochemistry, Platelet activation, Sphingosine and Platelet. The Cell biology study combines topics in areas such as Endothelial stem cell and GPVI. Many of his research projects under Biochemistry are closely connected to S1PR1 and Fibrinopeptide with S1PR1 and Fibrinopeptide, tying the diverse disciplines of science together.

His research in Platelet activation intersects with topics in Molecular physics, Radiation, Lymphatic Endothelium and Lymphangiogenesis. His work on Sphingosine-1-phosphate as part of general Sphingosine research is often related to Vascular endothelial growth factor C and Vascular endothelial growth factor B, thus linking different fields of science. His Platelet research includes themes of Diisopropyl fluorophosphate and Serine protease.

His most cited work include:

  • Sphingosine 1-Phosphate, a Bioactive Sphingolipid Abundantly Stored in Platelets, Is a Normal Constituent of Human Plasma and Serum (416 citations)
  • A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2 (377 citations)
  • Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. (356 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Cardiology, Platelet, Biochemistry and Platelet activation. His study in the field of Heart failure, Myocardial infarction and Acute coronary syndrome is also linked to topics like In patient. His Cardiology research is multidisciplinary, incorporating perspectives in Restenosis and Radiology.

His Platelet research is multidisciplinary, incorporating elements of Whole blood, Biophysics and Pharmacology. His Platelet activation research integrates issues from Receptor and Cell biology. His work carried out in the field of Cell biology brings together such families of science as Sphingosine and Sphingosine-1-phosphate.

He most often published in these fields:

  • Internal medicine (37.61%)
  • Cardiology (28.15%)
  • Platelet (22.07%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (37.61%)
  • Cardiology (28.15%)
  • Myocardial infarction (6.31%)

In recent papers he was focusing on the following fields of study:

Yukio Ozaki mainly investigates Internal medicine, Cardiology, Myocardial infarction, In patient and Cell biology. His biological study deals with issues like Endocrinology, which deal with fields such as Blood sampling. The concepts of his Cardiology study are interwoven with issues in Incidence and Rhythm.

His Cell biology research is multidisciplinary, incorporating elements of Platelet activation, Platelet, Stromal cell and Podoplanin. His Platelet activation research is multidisciplinary, relying on both Cell, Biochemistry, Adenosine and Gene. He combines subjects such as Extracellular, Receptor, Tyrosine phosphorylation, Cyclooxygenase and Aspirin with his study of Platelet.

Between 2013 and 2021, his most popular works were:

  • Thrombosis A Major Contributor to Global Disease Burden (315 citations)
  • Thrombosis: a major contributor to the global disease burden (170 citations)
  • Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial. (93 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Gene

His primary areas of study are Platelet, Podoplanin, Platelet activation, Cell biology and Receptor. In his study, Knockout mouse, Lung, Alveolar duct and Transforming growth factor is strongly linked to Cancer research, which falls under the umbrella field of Podoplanin. His research integrates issues of Receptor tyrosine kinase, MERTK, GAS6 and Tyrosine phosphorylation in his study of Platelet activation.

His Cell biology study integrates concerns from other disciplines, such as Hemostasis, Convulxin and Pathology. His Receptor research entails a greater understanding of Biochemistry. In his work, Internal medicine is strongly intertwined with Protein kinase B, which is a subfield of C-type lectin.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Sphingosine 1-Phosphate, a Bioactive Sphingolipid Abundantly Stored in Platelets, Is a Normal Constituent of Human Plasma and Serum

Yutaka Yatomi;Yasuyuki Igarashi;Libo Yang;Nobuo Hisano.
Journal of Biochemistry (1997)

636 Citations

Thrombosis A Major Contributor to Global Disease Burden

G.E. Raskob;P. Angchaisuksiri;A.N. Blanco;H. Buller.
Arteriosclerosis, Thrombosis, and Vascular Biology (2014)

507 Citations

A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2

Katsue Suzuki-Inoue;Gemma L J Fuller;Angel Garcia;Johannes A Eble.
Blood (2006)

479 Citations

Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.

Katsue Suzuki-Inoue;Yukinari Kato;Osamu Inoue;Mika Kato Kaneko.
Journal of Biological Chemistry (2007)

459 Citations

Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer.

Yukie Niwa;Hirohiko Akamatsu;Hayato Niwa;Hajime Sumi.
Clinical Cancer Research (2001)

334 Citations

Essential in vivo roles of the c-type lectin receptor CLEC-2: Embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets

Katsue Suzuki-Inoue;Osamu Inoue;Guo Ding;Satoshi Nishimura.
Journal of Biological Chemistry (2010)

303 Citations

Molecular analysis of the pathophysiological binding of the platelet aggregation‐inducing factor podoplanin to the C‐type lectin‐like receptor CLEC‐2

Yukinari Kato;Mika Kato Kaneko;Akiko Kunita;Hiromi Ito.
Cancer Science (2007)

271 Citations

Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2.

Tsukasa Ohmori;Yutaka Yatomi;Makoto Osada;Fuminori Kazama.
Cardiovascular Research (2003)

258 Citations

Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist

Makoto Osada;Yutaka Yatomi;Tsukasa Ohmori;Hitoshi Ikeda.
Biochemical and Biophysical Research Communications (2002)

257 Citations

Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.

Yutaka Yatomi;Yutaka Yatomi;Tsukasa Ohmori;Tsukasa Ohmori;Ge Rile;Ge Rile;Fuminori Kazama;Fuminori Kazama.
Blood (2000)

257 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Yukio Ozaki

Steve P. Watson

Steve P. Watson

University of Birmingham

Publications: 122

Yutaka Yatomi

Yutaka Yatomi

University of Tokyo

Publications: 56

Bernhard Nieswandt

Bernhard Nieswandt

University of Würzburg

Publications: 56

Elizabeth E. Gardiner

Elizabeth E. Gardiner

Australian National University

Publications: 53

Patrick W. Serruys

Patrick W. Serruys

National University of Ireland, Galway

Publications: 52

Timothy Hla

Timothy Hla

Boston Children's Hospital

Publications: 48

Sarah Spiegel

Sarah Spiegel

Virginia Commonwealth University

Publications: 47

Michael C. Berndt

Michael C. Berndt

Curtin University

Publications: 41

Johannes A. Eble

Johannes A. Eble

University of Münster

Publications: 38

Peter J. Newman

Peter J. Newman

Medical College of Wisconsin

Publications: 37

Jerold Chun

Jerold Chun

Discovery Institute

Publications: 36

Junken Aoki

Junken Aoki

University of Tokyo

Publications: 30

Yasuyuki Igarashi

Yasuyuki Igarashi

Hokkaido University

Publications: 29

Yoh Takuwa

Yoh Takuwa

Kanazawa University

Publications: 29

Gordon D. Brown

Gordon D. Brown

University of Exeter

Publications: 27

Joe G.N. Garcia

Joe G.N. Garcia

University of Arizona

Publications: 26

Trending Scientists

John Shalf

John Shalf

Lawrence Berkeley National Laboratory

Shigeki Sagayama

Shigeki Sagayama

University of Tokyo

Bing Zeng

Bing Zeng

University of Electronic Science and Technology of China

Meindert Niemeijer

Meindert Niemeijer

Digital Diagnostics Inc.

Francisco Javier Salvador

Francisco Javier Salvador

Universitat Politècnica de València

Takatomo Enoki

Takatomo Enoki

NTT (Japan)

Xiao Li Zhang

Xiao Li Zhang

Zhengzhou University

Catherine Tomasetto

Catherine Tomasetto

University of Strasbourg

David W. Andrews

David W. Andrews

Sunnybrook Health Science Centre

Steven Pawson

Steven Pawson

Goddard Space Flight Center

Bob J. Presley

Bob J. Presley

Texas A&M University

Hayley J. Fowler

Hayley J. Fowler

Newcastle University

Tina R. Goldstein

Tina R. Goldstein

University of Pittsburgh

Claudio Napoli

Claudio Napoli

University of Campania "Luigi Vanvitelli"

William F. Crowley

William F. Crowley

Harvard University

Andrew Stirling

Andrew Stirling

University of Sussex

Something went wrong. Please try again later.